121 related articles for article (PubMed ID: 23400941)
1. Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study.
Johannsen S; Berberich C; Metterlein T; Roth C; Reiners K; Roewer N; Schuster F
Muscle Nerve; 2013 May; 47(5):677-81. PubMed ID: 23400941
[TBL] [Abstract][Full Text] [Related]
2. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
[TBL] [Abstract][Full Text] [Related]
4. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
[TBL] [Abstract][Full Text] [Related]
5. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
[TBL] [Abstract][Full Text] [Related]
6. [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].
Schuster F; Hager M; Metterlein T; Muellenbach RM; Wurmb T; Wunder C; Roewer N; Anetseder M
Anaesthesist; 2008 Aug; 57(8):767-74. PubMed ID: 18563374
[TBL] [Abstract][Full Text] [Related]
7. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Cowan G; Karaian J; Muldoon S; Mongan P; Bünger R
Anesthesiology; 2006 Jan; 104(1):90-100. PubMed ID: 16394695
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
Mortier W; Breucking E
Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
[TBL] [Abstract][Full Text] [Related]
9. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
Weglinski MR; Wedel DJ; Engel AG
Anesth Analg; 1997 May; 84(5):1038-41. PubMed ID: 9141928
[TBL] [Abstract][Full Text] [Related]
11. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Muldoon S; Bünger R
Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
[TBL] [Abstract][Full Text] [Related]
13. Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia.
Malandrini A; Orrico A; Gaudiano C; Gambelli S; Galli L; Berti G; Tegazzin V; Dotti MT; Federico A; Sorrentino V
Anesthesiology; 2008 Oct; 109(4):625-8. PubMed ID: 18813041
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic hyperCKemia and malignant hyperthermia susceptibility.
Santos JM; Andrade PV; Galleni L; Vainzof M; Sobreira CFR; Schmidt B; Oliveira ASB; Amaral JLG; Silva HCA
Can J Anaesth; 2017 Dec; 64(12):1202-1210. PubMed ID: 28952030
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.
Schuster F; Metterlein T; Negele S; Gardill A; Schwemmer U; Roewer N; Anetseder M
Anesthesiology; 2007 Oct; 107(4):616-20. PubMed ID: 17893458
[TBL] [Abstract][Full Text] [Related]
19. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
Paasuke RT; Brownell AK
JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
[TBL] [Abstract][Full Text] [Related]
20. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
